Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-25

FDA Approved: PALSONIFY — Original Application (Crinetics Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Palsonify (paltusotine) from Crinetics Pharmaceuticals as an original drug approval for the treatment of acromegaly. This marks the first appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PALSONIFY (PALTUSOTINE)

Snippet

ORIG AP for PALSONIFY (PALTUSOTINE)